Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements OTC Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Press Releases and Statements CHPA Applauds New Mississippi Law to Prevent Unlawful Purchases of PSE-Containing Medicines Mar 21, 2025 OTC Monograph Product Technical Data Outline Advisory Documents
